Indago Appoints President and General Counsel

Indago, a medical device and technology company, announced that Leah Brownlee, J.D., has been appointed president and general counsel. Brownlee, an experienced life science executive, most recently served in the Corporate Practice and Life Sciences Industry groups at Squire Patton Boggs and previously served as executive vice president of Compliance and Operations at Cleveland BioLabs Inc., a clinical-stage NASDAQ-listed biotechnology company (CBLI).
 
Brownlee has served life science companies that range from startups to industry leaders across the pharmaceutical and medical device industries over the last 15 years.
 
“We couldn’t be happier to have Leah join the management team as Indago proceeds through the final stages of product development, regulatory approval, and commercial launch for its ArthroFree wireless arthroscopic camera system,” said Mark Froimson, M.D., board chairman.
 
“Leah’s vast experience in the life sciences sector, along with her leadership roles across public and private companies, makes her the ideal person to join Indago as we approach the marketing approval and launch of the ArthroFree system,” said Eugene Malinskiy, CEO.
 
“I am excited to be joining the Indago team as the company approaches critical milestones on the path to launching its first product,” Brownlee said. “I look forward to working alongside Eugene and the Indago team, leveraging my industry experience to help guide Indago as it grows.”